| CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears | Frank Vinluan | 08/14/20 | Europe |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone | Frank Vinluan | 09/06/19 | National |
| San Antonio Develops “Action Plan” to Draw Life Sciences Businesses | David Holley | 12/18/18 | Texas |
| With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines | Ben Fidler | 08/16/18 | New York |
| With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines | Ben Fidler | 06/11/18 | Boston |
| Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan | David Holley | 12/13/17 | Texas |
| Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 | David Holley | 11/29/17 | New York |
| Moderna Ends “Venture” Experiment, Dissolves Four Startups | Ben Fidler | 09/14/17 | Boston |
| San Diego’s Amplyx Raises $67M to Advance New Anti-Fungal Drug | Bruce V. Bigelow | 08/02/17 | San Diego |
| U-M Gets $2M to Study Xenex Robots’ Ability to Sanitize Hospitals | David Holley | 01/12/17 | Texas |
| Seattle’s Adaptive Bio to Base New Drug-Hunting Team in San Diego | Bruce V. Bigelow | 03/17/16 | San Diego |
| RayVio Absorbs $9.3M for UV Technology to Clean Water and Air | David Holley | 03/10/15 | San Francisco |
| Alnylam CEO: More Cash in Hand Is to Fuel Expansion From Within | Ben Fidler | 01/21/15 | Boston |
| More Green For Moderna as Merck Makes $50M Equity Grab, mRNA Deal | Ben Fidler | 01/13/15 | Boston |
| BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats | Frank Vinluan | 07/24/14 | Raleigh Durham |
| In Search of Meaningful GAIN in Renewal of Prescription Drug Act | Jeff Stein | 07/11/12 | San Diego |
| The Thinking Behind Domain’s $760M Life Sciences Deal in Russia | Bruce V. Bigelow | 03/07/12 | San Diego |
| Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News | Erin Kutz | 02/18/11 | Boston |
| Tachi Yamada, Gates Foundation’s Global Health Leader, Stepping Down in June | Luke Timmerman | 02/14/11 | Seattle |
| Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections | Luke Timmerman | 01/18/11 | Seattle |
| Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch | Luke Timmerman | 08/02/10 | Seattle |
| Seventh Sense, Rox Anderson and Bob Langer Startup, Seeks to Collect Blood With No Pain | Ryan McBride | 05/20/10 | Boston |
| Introducing Under-the-Radar Funding in San Diego: Four Startup Financings You Probably Haven’t Heard About | Erin Kutz | 03/31/10 | San Diego |
| Forma Therapeutics Snags $25.5M Venture Round, Punctuating Startup’s Breakout Year | Luke Timmerman | 12/01/09 | Boston |
| Novartis Parts Ways with Idera Pharma | Ryan McBride | 11/25/09 | Boston |
| AdvanDx Lands $8M for Series C | Ryan McBride | 08/18/09 | Boston |
| Pulmatrix Inhales $3M Financing | Ryan McBride | 03/13/09 | Boston |
| Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes | Ryan McBride | 12/18/08 | Boston |
